Evidence map›Paper›PMID 24367250›Full record

ArticlePLoS computational biology2013

A latent Markov modelling approach to the evaluation of circulating cathodic antigen strips for schistosomiasis diagnosis pre- and post-praziquantel treatment in Uganda.

Artemis Koukounari, Christl A Donnelly, Irini Moustaki, Edridah M Tukahebwa, Narcis B Kabatereine, Shona Wilson, Joanne P Webster, André M Deelder, Birgitte J Vennervald, Govert J van Dam

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Reconciling Egg- and Antigen-Based Estimates of Schistosoma mansoni Clearance and Reinfection: A Modeling Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Artemis KoukounariMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom ; Department of Statistics, London School of Economics and Political Science, London, United Kingdom.
Christl A DonnellyMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Irini MoustakiDepartment of Statistics, London School of Economics and Political Science, London, United Kingdom.
Edridah M TukahebwaSchistosomiasis Control Initiative at Vector Control Division - Ministry of Health, Kampala, Uganda.
Narcis B KabatereineSchistosomiasis Control Initiative at Vector Control Division - Ministry of Health, Kampala, Uganda.
Shona WilsonDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Joanne P WebsterDepartment of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
André M DeelderDepartment of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Birgitte J VennervaldSection for Parasitology and Aquatic Diseases, University of Copenhagen, Copenhagen, Denmark.
Govert J van DamDepartment of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Imperial College London · GBLeiden University Medical Center · NLLondon School of Economics and Political Science · GBMinistry of Health · UGUniversity of Cambridge · GBUniversity of Copenhagen · DK

Funding

Medical Research Council G0902130Medical Research Council G0902130/1Medical Research Council MR/K010174/1
6 · The paper itself

Abstract

Regular treatment with praziquantel (PZQ) is the strategy for human schistosomiasis control aiming to prevent morbidity in later life. With the recent resolution on schistosomiasis elimination by the 65th World Health Assembly, appropriate diagnostic tools to inform interventions are keys to their success. We present a discrete Markov chains modelling framework that deals with the longitudinal study design and the measurement error in the diagnostic methods under study. A longitudinal detailed dataset from Uganda, in which one or two doses of PZQ treatment were provided, was analyzed through Latent Markov Models (LMMs). The aim was to evaluate the diagnostic accuracy of Circulating Cathodic Antigen (CCA) and of double Kato-Katz (KK) faecal slides over three consecutive days for Schistosoma mansoni infection simultaneously by age group at baseline and at two follow-up times post treatment. Diagnostic test sensitivities and specificities and the true underlying infection prevalence over time as well as the probabilities of transitions between infected and uninfected states are provided. The estimated transition probability matrices provide parsimonious yet important insights into the re-infection and cure rates in the two age groups. We show that the CCA diagnostic performance remained constant after PZQ treatment and that this test was overall more sensitive but less specific than single-day double KK for the diagnosis of S. mansoni infection. The probability of clearing infection from baseline to 9 weeks was higher among those who received two PZQ doses compared to one PZQ dose for both age groups, with much higher re-infection rates among children compared to adolescents and adults. We recommend LMMs as a useful methodology for monitoring and evaluation and treatment decision research as well as CCA for mapping surveys of S. mansoni infection, although additional diagnostic tools should be incorporated in schistosomiasis elimination programs.

Indexed as

Markov ChainsAnthelminticsAntigens, ProtozoanHumansPraziquantelSchistosomiasisSensitivity and SpecificityUgandaAnthelminticsAntigens, ProtozoanPraziquantel

Identifiers

PMID24367250
PMCPMC3868541
OpenAlexW2155100165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.